We are monitoring the impact of COVID-19 on MEA Cartilage Regeneration Market Get in touch with us for detailed analysis Know More
Share on

Middle East and Africa Cartilage Regeneration Market Research Report – Segmented By Type Of Treatment, Application & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis on Size, Share, Trends, COVID-19 Impact & Growth Forecast (2022 to 2027)

Published: January, 2022
ID: 2517
Pages: 132

MEA Cartilage Regeneration Market Size (2022 to 2027)

The size of the Middle East and Africa Cartilage Regeneration Market was worth USD 71.82 million in 2022. It is further projected to be growing at a CAGR of 8.9% and worth USD 110.00 million by 2027.

The high prevalence and incidence rates of bone and joint disorders and the increasing number of cases of osteoarthritis and orthopedic injuries among the MEA population have resulted in an increased flow of patients to orthopedic clinics and hospitals. These factors are expected to drive the demand for cartilage regeneration in the near future in MEA. According to data released by the World Health Organization, 2016, around 1.5 million people die in traffic accidents worldwide each year due to the influence of drunk driving, reckless cell phone use, and other related factors such as bad weather conditions and inadequate road construction. In addition, there has been an increase in athletic activity in Saudi Arabia, which has raised the incidence of injury in athletes, leading to the demand for cartilage regeneration products. According to Marwan et al., the prevalence of various sports injuries recorded in many Arab nations was between 73% and 90%, especially in teenagers. According to research data from the American Orthopedic Society for Sports Medicine, more than 4 million athletes receive medical treatment for sports injuries each year.

The United Arab Emirates has a significant share of the elderly population. For example, the population over 65 is likely to increase significantly by 2030, according to the Dubai Health Investment Guide data. This increase in the elderly population indicates an increase in chronic diseases, which may increase the demand for cartilage regeneration procedures. In addition, the increasing technological upgrading and advancements in knee cartilage provide opportunities for the MEA cartilage regeneration market.

However, the high cost of cartilage repair surgeries and treatment, the complications associated with cartilage regeneration surgeries in the elderly, and the limited number of cartilage-based stem cell products may slow down the market growth for years to come. Additionally, the lack of skilled professionals and strict government regulations in the region is expected to challenge the market's growth rate during the forecast period.

This research report on the Middle East and Africa cartilage regeneration market has been segmented and sub-segmented into the following categories:

By Type Of Treatment: 

  • Cell-Based Approaches
    • Stem Cells
    • Growth Factor Technology
    • Chondrocyte Transplantation
  • Non-Cell-Based Approaches
    • Cell-Free Composites
    • Tissue Scaffolds

By Application: 

  • Hyaline Cartilage
  • Fibrocartilage

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Over the studied period, the regional market in Israel is expected to grow with the highest growth rate due to the increase in the number of older people and the availability of technologically advanced medical facilities in the region. Additionally, advancements have been made in the treatment of osteoarthritis, contributing to the growth of the cartilage repair market across the country.

Saudi Arabia is showing significant growth in the Middle East and Africa market due to the increase in road accidents and sports-related injuries. In addition, the government of Saudi Arabia has taken various measures to raise awareness of bone disease and repair. For example, the Department of Health has been vigilant about healthcare awareness to defeat the silent disease. A national osteoporosis awareness campaign was launched on World Osteoporosis Day. The campaign focuses attention on getting tested, treatment, and prevention, especially in women across KSA. In addition, the expansion of cartilage regeneration products will provide significant opportunities for the market in the near future.

The UAE dominates the Middle East and Africa cartilage regeneration market due to the increasing obesity, more cases of injuries and musculoskeletal disorders, increase in healthcare spending, government initiatives focused on providing better health services, and the growing number of health facilities. Notably, the establishment of efficient distribution networks by the country's leading manufacturers is likely to contribute to the future growth of the MEA cartilage regeneration market.


Companies playing a prominent role in the MEA cartilage regeneration market profiled in the report are Zimmer Biomet Holdings, Inc. (U.S.), Vericel Corporation (U.S.), Smith & Nephew plc (U.K.), Osiris Therapeutics, Inc. (U.S.), and Arthrex Inc. (U.S.).


                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

  1. Research Methodology

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

  1. Overview

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 Epidemology                                                              

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

  1. Market Segmentation

                5.1 Type of Treatment                                                  

                                5.1.1 Introduction                                           

                                5.1.2 Cell Based Approaches                                      

                                                       Stem Cells            

                                                       Growth Factor Technology           

                                                       Chondrocyte Transplantation      

                                5.1.3 Non-Cell Based Approaches                                            

                                                       Cell Free Composites      

                                                       Tissue Scaffolds 

                                5.1.4  Y-o-Y Growth Analysis, By Type of Treatment                                        

                                5.1.5  Market Attractiveness Analysis, By Type of Treatment                                      

                                5.1.6  Market Share Analysis, By Type of Treatment                                        

                5.2 Application                                                 

                                5.2.1 Introduction                                           

                                5.2.2 Hyaline Cartilage Regeneration                                      

                                5.2.3 Fibrocartilage Regeneration                                            

                                5.2.4 Y-o-Y Growth Analysis, By Application                                         

                                5.2.5 Market Attractiveness Analysis, By Application                                       

                                5.2.6 Market Share Analysis, By Application                                        

  1. Geographical Analysis

                6.1 Introduction                                                               

                                6.1.1 Regional Trends                                    

                                6.1.2 Impact Analysis                                     

                                6.1.3 Y-o-Y Growth Analysis                                        

                                       By Geographical Area                     

                                       By Type of Treatment                     

                                       By Application                    

                                6.1.4  Market Attractiveness Analysis                                     

                                       By Geographical Area                     

                                       By Type of Treatment                     

                                       By Application                    

                                6.1.5  Market Share Analysis                                      

                                       By Geographical Area                     

                                       By Type of Treatment                     

                                       By Application                    

                6.2 Middle-East                                                                

                6.3 Africa                                                            

7.Strategic Analysis                                                                        

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8.Market Leaders' Analysis                                                                         

                8.1 Zimmer Biomet Holdings                                                      

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Financial analysis                                  

                                8.1.4 Recent Developments                                       

                                8.1.5 SWOT analysis                                       

                                8.1.6 Analyst View                                          

                8.2 Vericel Corporation                                                 

                8.3 Smith & Nephew                                                     

                8.4 Osiris Therapeutics                                                  

                8.5 Arthrex                                                        

9.Competitive Landscape                                                                            

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10.Market Outlook and Investment Opportunities                                                                          


  1. a) List of Tables
  2. b) List of Figures
  1. Middle East & Africa Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Million)
  2. Middle East & Africa Cell Based Approaches Market By Region, From 2022 - 2027 (USD Million)
  3. Middle East & Africa Stem Cells Market By Region, From 2022 - 2027 (USD Million)
  4. Middle East & Africa Growth Factor Technology Market By Region, From 2022 - 2027 (USD Million)
  5. Middle East & Africa Chondrocyte Transplantation Market By Region, From 2022 - 2027 (USD Million)
  6. Middle East & Africa Non-Cell Based Approaches Market By Region, From 2022 - 2027 (USD Million)
  7. Middle East & Africa Cell Free Composites Market By Region, From 2022 - 2027 (USD Million)
  8. Middle East & Africa Tissue Scaffolds Market By Region, From 2022 - 2027 (USD Million)
  9. Middle East & Africa Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Million)
  10. Middle East & Africa Hyaline Cartilage Regeneration Market By Region, From 2022 - 2027 (USD Million)
  11. Middle East & Africa Fibrocartilage Regeneration Market By Region, From 2022 - 2027 (USD Million)
  12. Middle East Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Million)
  13. Middle East Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Million)
  14. Africa Cartilage Regeneration Market, By Type of Treatment, From 2022 - 2027 (USD Million) 
  15. Africa Cartilage Regeneration Market, By Application, From 2022 - 2027 (USD Million)

Please wait. . . . Your request is being processed

Related Reports




pdf excel


pdf excel powerbi




What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.

Talk to our analyst and get customised report done according to your research needs


Check if you can avail any discount. Submit your details and our team will get back to you.


Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2875

Didn’t find what you’re looking for?

Find it too expensive?

Click for Request Sample